Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

Accueil
Investir
Divers
LSE
Inter-amer 30 (BC43)
Inter-amer 30 (BC43) Actualités

BC43

Inter-amer 30 (BC43)

Inter-amer 30

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:LSE:BC43

Date	Heure	Source	Titre	Symbole	Société
13/11/2002	15h09	UK Regulatory	Rebecca O. Kendall Announces Retirement; Robert A. Armitage Promoted to Lilly Senior Vice President, General Counsel	LSE:BC43	Inter-amer 30
09/11/2002	10h30	UK Regulatory	Eli Lilly and Company	LSE:BC43	Inter-amer 30
08/11/2002	13h30	UK Regulatory	Lilly Outlines to Wall Street Its Strategy To Realize Its Growth Opportunities and Deliver Superior Earnings Growth Over the Lon	LSE:BC43	Inter-amer 30
29/10/2002	15h00	UK Regulatory	Cymbalta Data Suggest Rapid and Sustained Response by First Week of Therapy	LSE:BC43	Inter-amer 30
23/10/2002	14h10	UK Regulatory	3rd Quarter Results	LSE:BC43	Inter-amer 30
22/10/2002	09h01	UK Regulatory	Alimta Continues To Show Versatility in Treating Different Cancers	LSE:BC43	Inter-amer 30
21/10/2002	22h15	UK Regulatory	Dividend Declaration	LSE:BC43	Inter-amer 30
18/10/2002	09h00	UK Regulatory	Combining Innovative Therapies for Optimal Cancer Care; Effectiveness of Gemzar-Based Combination Regimens is Topic of Workshop	LSE:BC43	Inter-amer 30
01/10/2002	16h10	UK Regulatory	Newly Published Study Demonstrates Sustained Efficacy of Evista -raloxifene HCl- in Reducing Risk of Spinal Fractures	LSE:BC43	Inter-amer 30
25/09/2002	23h59	UK Regulatory	Lilly Asserts The New England Journal of Medicine ``Sounding Board'' Opinion Article Attempts to Turn Back the Clock on Care of	LSE:BC43	Inter-amer 30
24/09/2002	23h39	UK Regulatory	Re Alliance	LSE:BC43	Inter-amer 30
20/09/2002	15h07	UK Regulatory	Statement re	LSE:BC43	Inter-amer 30
17/09/2002	16h34	UK Regulatory	Lilly Launches World's Largest Severe Sepsis Clinical Trial; 11,000 Patients to be Enrolled in Study of Xigris Use in Patients w	LSE:BC43	Inter-amer 30
16/09/2002	19h02	UK Regulatory	FDA Issues Approvable Letter for Lilly's Cymbalta for Treatment of Depression; From the Makers of Prozac, Cymbalta Will Offer Ne	LSE:BC43	Inter-amer 30
16/09/2002	16h04	UK Regulatory	Miscellaneous	LSE:BC43	Inter-amer 30
03/09/2002	16h08	UK Regulatory	Tadalafil for the Treatment of Erectile Dysfunction Receives Positive Recommendation From the Australian Drug Evaluation Committ	LSE:BC43	Inter-amer 30
26/08/2002	21h11	UK Regulatory	Regulatory Approval	LSE:BC43	Inter-amer 30
14/08/2002	15h29	UK Regulatory	FDA Issues Approvable Letter for Strattera for ADHD; Strattera Would Give Patients, Families and Physicians a New Treatment Opti	LSE:BC43	Inter-amer 30
01/08/2002	09h23	UK Regulatory	Lilly's Xigris Becomes First and Only Medical Product Approved for BIPA Payment in Medicare Patients	LSE:BC43	Inter-amer 30
25/07/2002	22h03	UK Regulatory	Lilly ICOS LLC	LSE:BC43	Inter-amer 30
30/04/2002	17h55	UK Regulatory	Financial Expectations-Update	LSE:BC43	Inter-amer 30
16/04/2002	11h25	UK Regulatory	Dividend	LSE:BC43	Inter-amer 30
15/04/2002	17h35	UK Regulatory	1st Quarter Results	LSE:BC43	Inter-amer 30
15/04/2002	09h00	RNS Non-Regulatory	Collaboration Extended	LSE:BC43	Lilly (Eli) & Co
25/03/2002	12h13	UK Regulatory	Annual Report and Accts etc	LSE:BC43	Inter-amer 30
20/03/2002	16h08	RNS Non-Regulatory	Translational Medicine Award	LSE:BC43	Lilly (Eli) & Co
20/03/2002	08h00	UK Regulatory	Research Update	LSE:BC43	Inter-amer 30
12/03/2002	19h07	RNS Non-Regulatory	Patient Assistance Program	LSE:BC43	Lilly (Eli) & Co
05/03/2002	10h08	UK Regulatory	2002 Xigris Sales	LSE:BC43	Inter-amer 30
20/02/2002	08h05	UK Regulatory	Directorate Change	LSE:BC43	Inter-amer 30

Showing the most relevant articles for your search:LSE:BC43

Cie de SaintGobain

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales